DIA
Drug Information Association Logo
« Back to Listing

Delivering Value Through Medical Content to Health Care Providers

Track:
Medical Communication, Medical Writing, and Medical Science Liaison

Day & Time:
June 16, 8:30AM - 10:00AM (Pacific Standard Time)

Session Number:
108

Room Number:
31AB

Level:
Intermediate

Type:
Session

Title:
Delivering Value Through Medical Content to Health Care Providers

Chair(s):
Robin L. Winter-Sperry, MD
President and Chief Executive Officer
Scientific Advantage LLC, United States

Description:
Pharmaceutical companies have an obligation to provide medical content, while maintaining a balance that protects patients. This medical content is regularly provided reactively and often contains information outside of the approved label to respond to questions received from health care providers. This off-label communication is a part of the product life cycle, and guidance for providing this content is currently provided by FDA draft guidance. This session will discuss the delivery of medical communications, both on-label and off-label, to a variety of health care audiences. Several aspects of creating content and differing delivery formats will be addressed.

Learning Objective(s):
Discuss how free is “free exchange” for scientific communication; Identify how to balance essential clinical information, communication boundaries and effective venues; Discuss the importance of providing a consistent medical message across boarders; Define the how, what, when, where and why for appropriate scientific exchange.

Presentation(s) & Speaker(s):
The Art of Medical Communication: Setting the Stage
Robin L. Winter-Sperry, MD
President and Chief Executive Officer
Scientific Advantage LLC, United States

Current US Legal Healthcare Industry Environment
John T. Vaughan, JD
Chief Regulatory Counsel
Hospira, United States

Defining the Role of the MIS and MSL
Dannis Y. Chang, PharmD
Medical Communications Scientist
Genentech, A Member of the Roche Group, United States

Going Global: One Step at a Time
Bethany L. Drimalla, PharmD, MS
Manager, Global Oncology Medical Information
Novartis Pharmaceuticals Corporation, United States